1.	Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: McG 0722, NCT00779896
2.	Phase II Study of Topical Tazarotene in Patients With Basal Cell Nevus Syndrome and Basal Cell Carcinoma on the Face Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: NCI Protocol IDs: CHORI-2007-016, UCSF-05862, R01-CA-109584, NCT00489086, 05862
3.	Phase II Randomized Study of Tazarotene Applied to Patients with Basal Cell Carcinoma and Basal Cell Nevus Syndrome on the Chest and Back Phase: Phase II Type: Treatment Status: Active Age: 18 - 75 Sponsor: NCI Protocol IDs: CHORI-2007-022, 05862, CHORI-H473-26042, NCT00783965